Literature DB >> 16807539

Vascular defect beyond the endothelium in type II diabetic patients with overt nephropathy and moderate renal insufficiency.

W B Chan1, N N Chan, C W K Lai, W Y So, M K W Lo, K F Lee, C C Chow, C Metreweli, J C N Chan.   

Abstract

There is a paucity of data on the effects of overt nephropathy and moderate renal impairment on endothelial function in diabetic patients. A total of 26 type II diabetic (DM) patients with nephropathy (DMN+) (mean +/- s.d. age: 63.7 +/- 6.3 years), 32 diabetic patients without nephropathy (DMN-) (59.4 +/- 10.1 years), and 52 non-diabetic subjects (54.9 +/- 8.2 years) were recruited. High-resolution ultrasound scan was used to measure carotid intima media thickness (IMT) and flow-mediated dilation (FMD) of the brachial artery. Endothelium-independent dilation was determined by maximal vascular dilation after sublingual nitroglycerine (glyceryl trinitrate (GTN)-induced dilation). The mean carotid IMT increased progressively from non-DM to DMN- to DMN+ groups (0.74 +/- 0.23 vs 0.80 +/- 0.25 vs 1.03 +/- 0.38 mm; P=0.001 for trend) whereas FMD- (4.3 +/- 2.5 vs 3.9 +/- 1.7 vs 1.9 +/- 2.0%, P<0.001 for trend) and GTN-induced dilation (14.7 +/- 4.0 vs 14.5 +/- 3.9 vs 10.3 +/- 3.2%; P<0.001 for trend) declined in an opposite manner. On multivariate analysis, age (beta=0.257, P=0.009), glomerular filtration rate (beta=-0.364, P<0.001), and smoking (beta=0.25, P=0.013) were independently associated with carotid IMT (F=15.76, R(2)=0.340, P<0.001). After adjustment for baseline brachial arterial diameter, history of smoking (beta=-0.039, P<0.001), fasting plasma glucose (beta=-0.033, P=0.002), and total cholesterol (beta=-0.023, P=0.024) were independently associated with vessel diameter after FMD (F=2446.5, R(2)=0.992, P<0.001); whereas age (beta=-0.069, P=0.001) and urinary albumin excretion (beta=-0.048, P=0.018) were independently associated with vessel diameter after GTN (F=851.6, R(2)=0.967, P<0.001). Type II diabetic patients with overt nephropathy and moderate renal impairment had both structural and functional vascular abnormalities beyond the endothelium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807539     DOI: 10.1038/sj.ki.5001652

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease.

Authors:  Tal Kopel; James S Kaufman; Naomi Hamburg; John S Sampalis; Joseph A Vita; Laura M Dember
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 8.237

2.  eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists.

Authors:  Tomoki Kosugi; Marcelo Heinig; Takahiro Nakayama; Seiichi Matsuo; Takahiko Nakagawa
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

3.  Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice.

Authors:  Jinhua Li; Xinli Qu; John F Bertram
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

4.  Flow Mediated Dilatation Is Reduced with the Progressive Stages of Glomerular Filtration Rate and Albuminuria in Type 2 Diabetic Patients without Coronary Heart Disease.

Authors:  Hiroyuki Ito; Mina Nakashima; Kentaro Meguro; Haruki Furukawa; Hitomi Yamashita; Akifusa Takaki; Chizuko Yukawa; Takashi Omoto; Masahiro Shinozaki; Shinya Nishio; Mariko Abe; Shinichi Antoku; Mizuo Mifune; Michiko Togane
Journal:  J Diabetes Res       Date:  2015-04-29       Impact factor: 4.011

5.  Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population.

Authors:  Christodoula Kourtidou; Vasileios Rafailidis; Garyfallia Varouktsi; Efthimios Kanakis; Vassilios Liakopoulos; Timoleon-Achilleas Vyzantiadis; Maria Stangou; Smaragdi Marinaki; Konstantinos Tziomalos
Journal:  J Pers Med       Date:  2022-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.